APO Research, Inc.

APO RESEARCH · REPORT

Anti-worm Medication

Selected research

Market Structure

Global Anti-worm Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Anti-worm Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anti-worm Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-worm Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-worm Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-worm Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-worm Medication include Boehringer Ingelheim, Chanelle Group, Dechra, Elanco, Fredun Pharmaceuticals Ltd, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Salius Pharma and Sequent Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-worm Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-worm Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-worm Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-worm Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-worm Medication Segment by Company

Boehringer Ingelheim

Chanelle Group

Dechra

Elanco

Fredun Pharmaceuticals Ltd

K.A. Malle Pharmaceuticals

Lasa Supergenerics Limited

Salius Pharma

Sequent Scientific

Supharma Chem

Vetoquinol

Virbac

Zoetis

Bayer

GlaxoSmithKline

Zhongjia Pharmaceutical

Huazhong Pharmaceutical

Jiangsu Qihui

Merck Animal Health

Anti-worm Medication Segment by Type

Albenza

Vermox

Anti-worm Medication Segment by Application

Human

Veterinary

Anti-worm Medication Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-worm Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-worm Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-worm Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-worm Medication market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-worm Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-worm Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anti-worm Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anti-worm Medication Industry Trends Table 2. Anti-worm Medication Industry Drivers Table 3. Anti-worm Medication Industry Opportunities and Challenges Table 4. Anti-worm Medication Industry Restraints Table 5. Global Anti-worm Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anti-worm Medication Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anti-worm Medication Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Anti-worm Medication Sales Market Share by Manufacturers Table 9. Global Anti-worm Medication Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Anti-worm Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anti-worm Medication Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anti-worm Medication Manufacturers, Product Type & Application Table 13. Global Anti-worm Medication Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-worm Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Albenza Table 17. Major Manufacturers of Vermox Table 18. Global Anti-worm Medication Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Anti-worm Medication Sales by Type (2021-2026) & (K Units) Table 20. Global Anti-worm Medication Sales by Type (2027-2032) & (K Units) Table 21. Global Anti-worm Medication Sales Market Share by Type (2021-2026) Table 22. Global Anti-worm Medication Sales Market Share by Type (2027-2032) Table 23. Global Anti-worm Medication Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Anti-worm Medication Revenue by Type (2021-2026) & (K Units) Table 25. Global Anti-worm Medication Revenue by Type (2027-2032) & (K Units) Table 26. Global Anti-worm Medication Revenue Market Share by Type (2021-2026) Table 27. Global Anti-worm Medication Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Human Table 29. Major Manufacturers of Veterinary Table 30. Global Anti-worm Medication Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Anti-worm Medication Sales by Application (2021-2026) & (K Units) Table 32. Global Anti-worm Medication Sales by Application (2027-2032) & (K Units) Table 33. Global Anti-worm Medication Sales Market Share by Application (2021-2026) Table 34. Global Anti-worm Medication Sales Market Share by Application (2027-2032) Table 35. Global Anti-worm Medication Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Anti-worm Medication Revenue by Application (2021-2026) & (K Units) Table 37. Global Anti-worm Medication Revenue by Application (2027-2032) & (K Units) Table 38. Global Anti-worm Medication Revenue Market Share by Application (2021-2026) Table 39. Global Anti-worm Medication Revenue Market Share by Application (2027-2032) Table 40. Global Anti-worm Medication Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Anti-worm Medication Sales by Region (2021-2026) & (K Units) Table 42. Global Anti-worm Medication Sales Market Share by Region (2021-2026) Table 43. Global Anti-worm Medication Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Anti-worm Medication Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Anti-worm Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Anti-worm Medication Sales by Country (2021-2026) & (K Units) Table 47. North America Anti-worm Medication Sales by Country (2027-2032) & (K Units) Table 48. Europe Anti-worm Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Anti-worm Medication Sales by Country (2021-2026) & (K Units) Table 50. Europe Anti-worm Medication Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Anti-worm Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Anti-worm Medication Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Anti-worm Medication Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Anti-worm Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Anti-worm Medication Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Anti-worm Medication Sales by Country (2027-2032) & (K Units) Table 57. Global Anti-worm Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Anti-worm Medication Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Anti-worm Medication Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Anti-worm Medication Revenue Market Share by Region (2021-2026) Table 61. Global Anti-worm Medication Revenue Market Share by Region (2027-2032) Table 62. Boehringer Ingelheim Company Information Table 63. Boehringer Ingelheim Business Overview Table 64. Boehringer Ingelheim Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Boehringer Ingelheim Anti-worm Medication Product Portfolio Table 66. Boehringer Ingelheim Recent Development Table 67. Chanelle Group Company Information Table 68. Chanelle Group Business Overview Table 69. Chanelle Group Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Chanelle Group Anti-worm Medication Product Portfolio Table 71. Chanelle Group Recent Development Table 72. Dechra Company Information Table 73. Dechra Business Overview Table 74. Dechra Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Dechra Anti-worm Medication Product Portfolio Table 76. Dechra Recent Development Table 77. Elanco Company Information Table 78. Elanco Business Overview Table 79. Elanco Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Elanco Anti-worm Medication Product Portfolio Table 81. Elanco Recent Development Table 82. Fredun Pharmaceuticals Ltd Company Information Table 83. Fredun Pharmaceuticals Ltd Business Overview Table 84. Fredun Pharmaceuticals Ltd Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Fredun Pharmaceuticals Ltd Anti-worm Medication Product Portfolio Table 86. Fredun Pharmaceuticals Ltd Recent Development Table 87. K.A. Malle Pharmaceuticals Company Information Table 88. K.A. Malle Pharmaceuticals Business Overview Table 89. K.A. Malle Pharmaceuticals Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. K.A. Malle Pharmaceuticals Anti-worm Medication Product Portfolio Table 91. K.A. Malle Pharmaceuticals Recent Development Table 92. Lasa Supergenerics Limited Company Information Table 93. Lasa Supergenerics Limited Business Overview Table 94. Lasa Supergenerics Limited Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Lasa Supergenerics Limited Anti-worm Medication Product Portfolio Table 96. Lasa Supergenerics Limited Recent Development Table 97. Salius Pharma Company Information Table 98. Salius Pharma Business Overview Table 99. Salius Pharma Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Salius Pharma Anti-worm Medication Product Portfolio Table 101. Salius Pharma Recent Development Table 102. Sequent Scientific Company Information Table 103. Sequent Scientific Business Overview Table 104. Sequent Scientific Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Sequent Scientific Anti-worm Medication Product Portfolio Table 106. Sequent Scientific Recent Development Table 107. Supharma Chem Company Information Table 108. Supharma Chem Business Overview Table 109. Supharma Chem Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Supharma Chem Anti-worm Medication Product Portfolio Table 111. Supharma Chem Recent Development Table 112. Vetoquinol Company Information Table 113. Vetoquinol Business Overview Table 114. Vetoquinol Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Vetoquinol Anti-worm Medication Product Portfolio Table 116. Vetoquinol Recent Development Table 117. Virbac Company Information Table 118. Virbac Business Overview Table 119. Virbac Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Virbac Anti-worm Medication Product Portfolio Table 121. Virbac Recent Development Table 122. Zoetis Company Information Table 123. Zoetis Business Overview Table 124. Zoetis Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Zoetis Anti-worm Medication Product Portfolio Table 126. Zoetis Recent Development Table 127. Bayer Company Information Table 128. Bayer Business Overview Table 129. Bayer Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Bayer Anti-worm Medication Product Portfolio Table 131. Bayer Recent Development Table 132. GlaxoSmithKline Company Information Table 133. GlaxoSmithKline Business Overview Table 134. GlaxoSmithKline Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. GlaxoSmithKline Anti-worm Medication Product Portfolio Table 136. GlaxoSmithKline Recent Development Table 137. Zhongjia Pharmaceutical Company Information Table 138. Zhongjia Pharmaceutical Business Overview Table 139. Zhongjia Pharmaceutical Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Zhongjia Pharmaceutical Anti-worm Medication Product Portfolio Table 141. Zhongjia Pharmaceutical Recent Development Table 142. Huazhong Pharmaceutical Company Information Table 143. Huazhong Pharmaceutical Business Overview Table 144. Huazhong Pharmaceutical Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Huazhong Pharmaceutical Anti-worm Medication Product Portfolio Table 146. Huazhong Pharmaceutical Recent Development Table 147. Jiangsu Qihui Company Information Table 148. Jiangsu Qihui Business Overview Table 149. Jiangsu Qihui Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Jiangsu Qihui Anti-worm Medication Product Portfolio Table 151. Jiangsu Qihui Recent Development Table 152. Merck Animal Health Company Information Table 153. Merck Animal Health Business Overview Table 154. Merck Animal Health Anti-worm Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Merck Animal Health Anti-worm Medication Product Portfolio Table 156. Merck Animal Health Recent Development Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Anti-worm Medication Distributors List Table 160. Anti-worm Medication Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Anti-worm Medication Product Image Figure 2. Global Anti-worm Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-worm Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-worm Medication Sales (2021-2032) & (K Units) Figure 5. Global Anti-worm Medication Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anti-worm Medication Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Albenza Image Figure 9. Vermox Image Figure 10. Global Anti-worm Medication Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Anti-worm Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Anti-worm Medication Sales Market Share by Type (2021-2032) Figure 13. Global Anti-worm Medication Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Anti-worm Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Anti-worm Medication Revenue Market Share by Type (2021-2032) Figure 16. Human Image Figure 17. Veterinary Image Figure 18. Global Anti-worm Medication Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Anti-worm Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Anti-worm Medication Sales Market Share by Application (2021-2032) Figure 21. Global Anti-worm Medication Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Anti-worm Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Anti-worm Medication Revenue Market Share by Application (2021-2032) Figure 24. North America Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Anti-worm Medication Sales Market Share by Country (2021-2032) Figure 26. U.S. Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Anti-worm Medication Sales Market Share by Country (2021-2032) Figure 31. Germany Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Anti-worm Medication Sales Market Share by Country (2021-2032) Figure 38. China Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Anti-worm Medication Sales Market Share by Country (2021-2032) Figure 46. Brazil Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Anti-worm Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Anti-worm Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Anti-worm Medication Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Anti-worm Medication Revenue (2021-2032) & (US$ Million) Figure 57. North America Anti-worm Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Anti-worm Medication Revenue (2021-2032) & (US$ Million) Figure 59. Europe Anti-worm Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Anti-worm Medication Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Anti-worm Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Anti-worm Medication Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Anti-worm Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Anti-worm Medication Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Anti-worm Medication Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Albenza
  • Vermox
Applications
  • Human
  • Veterinary
Companies covered
  • Boehringer Ingelheim
  • Chanelle Group
  • Dechra
  • Elanco
  • Fredun Pharmaceuticals Ltd
  • K.A. Malle Pharmaceuticals
  • Lasa Supergenerics Limited
  • Salius Pharma
  • Sequent Scientific
  • Supharma Chem
  • Vetoquinol
  • Virbac
  • Zoetis
  • Bayer
  • GlaxoSmithKline
  • Zhongjia Pharmaceutical
  • Huazhong Pharmaceutical
  • Jiangsu Qihui
  • Merck Animal Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-worm Medication Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-worm Medication Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anti-worm Medication Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anti-worm Medication Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anti-worm Medication Market Dynamics
  1. 2.1 Anti-worm Medication Industry Trends
  2. 2.2 Anti-worm Medication Industry Drivers
  3. 2.3 Anti-worm Medication Industry Opportunities and Challenges
  4. 2.4 Anti-worm Medication Industry Restraints
3 Anti-worm Medication Market by Manufacturers
  1. 3.1 Global Anti-worm Medication Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anti-worm Medication Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anti-worm Medication Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anti-worm Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-worm Medication Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anti-worm Medication Manufacturers, Product Type & Application
  7. 3.7 Global Anti-worm Medication Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-worm Medication Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-worm Medication Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-worm Medication Tier 1, Tier 2, and Tier 3
4 Anti-worm Medication Market by Type
  1. 4.1 Anti-worm Medication Type Introduction
  2. 4.1.1 Albenza
  3. 4.1.2 Vermox
  4. 4.2 Global Anti-worm Medication Sales by Type
  5. 4.2.1 Global Anti-worm Medication Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Anti-worm Medication Sales by Type (2021-2032)
  7. 4.2.3 Global Anti-worm Medication Sales Market Share by Type (2021-2032)
  8. 4.3 Global Anti-worm Medication Revenue by Type
  9. 4.3.1 Global Anti-worm Medication Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Anti-worm Medication Revenue by Type (2021-2032)
  11. 4.3.3 Global Anti-worm Medication Revenue Market Share by Type (2021-2032)
5 Anti-worm Medication Market by Application
  1. 5.1 Anti-worm Medication Application Introduction
  2. 5.1.1 Human
  3. 5.1.2 Veterinary
  4. 5.2 Global Anti-worm Medication Sales by Application
  5. 5.2.1 Global Anti-worm Medication Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Anti-worm Medication Sales by Application (2021-2032)
  7. 5.2.3 Global Anti-worm Medication Sales Market Share by Application (2021-2032)
  8. 5.3 Global Anti-worm Medication Revenue by Application
  9. 5.3.1 Global Anti-worm Medication Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Anti-worm Medication Revenue by Application (2021-2032)
  11. 5.3.3 Global Anti-worm Medication Revenue Market Share by Application (2021-2032)
6 Global Anti-worm Medication Sales by Region
  1. 6.1 Global Anti-worm Medication Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-worm Medication Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-worm Medication Sales by Region (2021-2026)
  4. 6.2.2 Global Anti-worm Medication Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-worm Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anti-worm Medication Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anti-worm Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anti-worm Medication Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anti-worm Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anti-worm Medication Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anti-worm Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anti-worm Medication Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anti-worm Medication Revenue by Region
  1. 7.1 Global Anti-worm Medication Revenue by Region
  2. 7.1.1 Global Anti-worm Medication Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anti-worm Medication Revenue by Region (2021-2026)
  4. 7.1.3 Global Anti-worm Medication Revenue by Region (2027-2032)
  5. 7.1.4 Global Anti-worm Medication Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anti-worm Medication Revenue (2021-2032)
  8. 7.2.2 North America Anti-worm Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anti-worm Medication Revenue (2021-2032)
  11. 7.3.2 Europe Anti-worm Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anti-worm Medication Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anti-worm Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anti-worm Medication Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anti-worm Medication Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Anti-worm Medication Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Chanelle Group
  8. 8.2.1 Chanelle Group Company Information
  9. 8.2.2 Chanelle Group Business Overview
  10. 8.2.3 Chanelle Group Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Chanelle Group Anti-worm Medication Product Portfolio
  12. 8.2.5 Chanelle Group Recent Developments
  13. 8.3 Dechra
  14. 8.3.1 Dechra Company Information
  15. 8.3.2 Dechra Business Overview
  16. 8.3.3 Dechra Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dechra Anti-worm Medication Product Portfolio
  18. 8.3.5 Dechra Recent Developments
  19. 8.4 Elanco
  20. 8.4.1 Elanco Company Information
  21. 8.4.2 Elanco Business Overview
  22. 8.4.3 Elanco Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Anti-worm Medication Product Portfolio
  24. 8.4.5 Elanco Recent Developments
  25. 8.5 Fredun Pharmaceuticals Ltd
  26. 8.5.1 Fredun Pharmaceuticals Ltd Company Information
  27. 8.5.2 Fredun Pharmaceuticals Ltd Business Overview
  28. 8.5.3 Fredun Pharmaceuticals Ltd Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fredun Pharmaceuticals Ltd Anti-worm Medication Product Portfolio
  30. 8.5.5 Fredun Pharmaceuticals Ltd Recent Developments
  31. 8.6 K.A. Malle Pharmaceuticals
  32. 8.6.1 K.A. Malle Pharmaceuticals Company Information
  33. 8.6.2 K.A. Malle Pharmaceuticals Business Overview
  34. 8.6.3 K.A. Malle Pharmaceuticals Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 K.A. Malle Pharmaceuticals Anti-worm Medication Product Portfolio
  36. 8.6.5 K.A. Malle Pharmaceuticals Recent Developments
  37. 8.7 Lasa Supergenerics Limited
  38. 8.7.1 Lasa Supergenerics Limited Company Information
  39. 8.7.2 Lasa Supergenerics Limited Business Overview
  40. 8.7.3 Lasa Supergenerics Limited Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lasa Supergenerics Limited Anti-worm Medication Product Portfolio
  42. 8.7.5 Lasa Supergenerics Limited Recent Developments
  43. 8.8 Salius Pharma
  44. 8.8.1 Salius Pharma Company Information
  45. 8.8.2 Salius Pharma Business Overview
  46. 8.8.3 Salius Pharma Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Salius Pharma Anti-worm Medication Product Portfolio
  48. 8.8.5 Salius Pharma Recent Developments
  49. 8.9 Sequent Scientific
  50. 8.9.1 Sequent Scientific Company Information
  51. 8.9.2 Sequent Scientific Business Overview
  52. 8.9.3 Sequent Scientific Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sequent Scientific Anti-worm Medication Product Portfolio
  54. 8.9.5 Sequent Scientific Recent Developments
  55. 8.10 Supharma Chem
  56. 8.10.1 Supharma Chem Company Information
  57. 8.10.2 Supharma Chem Business Overview
  58. 8.10.3 Supharma Chem Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Supharma Chem Anti-worm Medication Product Portfolio
  60. 8.10.5 Supharma Chem Recent Developments
  61. 8.11 Vetoquinol
  62. 8.11.1 Vetoquinol Company Information
  63. 8.11.2 Vetoquinol Business Overview
  64. 8.11.3 Vetoquinol Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Vetoquinol Anti-worm Medication Product Portfolio
  66. 8.11.5 Vetoquinol Recent Developments
  67. 8.12 Virbac
  68. 8.12.1 Virbac Company Information
  69. 8.12.2 Virbac Business Overview
  70. 8.12.3 Virbac Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Virbac Anti-worm Medication Product Portfolio
  72. 8.12.5 Virbac Recent Developments
  73. 8.13 Zoetis
  74. 8.13.1 Zoetis Company Information
  75. 8.13.2 Zoetis Business Overview
  76. 8.13.3 Zoetis Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Zoetis Anti-worm Medication Product Portfolio
  78. 8.13.5 Zoetis Recent Developments
  79. 8.14 Bayer
  80. 8.14.1 Bayer Company Information
  81. 8.14.2 Bayer Business Overview
  82. 8.14.3 Bayer Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bayer Anti-worm Medication Product Portfolio
  84. 8.14.5 Bayer Recent Developments
  85. 8.15 GlaxoSmithKline
  86. 8.15.1 GlaxoSmithKline Company Information
  87. 8.15.2 GlaxoSmithKline Business Overview
  88. 8.15.3 GlaxoSmithKline Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 GlaxoSmithKline Anti-worm Medication Product Portfolio
  90. 8.15.5 GlaxoSmithKline Recent Developments
  91. 8.16 Zhongjia Pharmaceutical
  92. 8.16.1 Zhongjia Pharmaceutical Company Information
  93. 8.16.2 Zhongjia Pharmaceutical Business Overview
  94. 8.16.3 Zhongjia Pharmaceutical Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Zhongjia Pharmaceutical Anti-worm Medication Product Portfolio
  96. 8.16.5 Zhongjia Pharmaceutical Recent Developments
  97. 8.17 Huazhong Pharmaceutical
  98. 8.17.1 Huazhong Pharmaceutical Company Information
  99. 8.17.2 Huazhong Pharmaceutical Business Overview
  100. 8.17.3 Huazhong Pharmaceutical Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Huazhong Pharmaceutical Anti-worm Medication Product Portfolio
  102. 8.17.5 Huazhong Pharmaceutical Recent Developments
  103. 8.18 Jiangsu Qihui
  104. 8.18.1 Jiangsu Qihui Company Information
  105. 8.18.2 Jiangsu Qihui Business Overview
  106. 8.18.3 Jiangsu Qihui Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Jiangsu Qihui Anti-worm Medication Product Portfolio
  108. 8.18.5 Jiangsu Qihui Recent Developments
  109. 8.19 Merck Animal Health
  110. 8.19.1 Merck Animal Health Company Information
  111. 8.19.2 Merck Animal Health Business Overview
  112. 8.19.3 Merck Animal Health Anti-worm Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Merck Animal Health Anti-worm Medication Product Portfolio
  114. 8.19.5 Merck Animal Health Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-worm Medication Value Chain Analysis
  2. 9.1.1 Anti-worm Medication Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-worm Medication Production Mode & Process
  6. 9.2 Anti-worm Medication Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-worm Medication Distributors
  9. 9.2.3 Anti-worm Medication Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.